William Blair boosts NxStage stake by 20% | Wall Street Beat

February 5, 2013 by MassDevice staff

William Blair & Co. added 20% to its stake in medical device company NxStage Medical, which makes home hemodialysis equipment.

MassDevice.com Wall Street Beat

William Blair & Co. added 20% to its holdings in NxStage Medical (NSDQ:NXTM) last year, according to regulatory filings.

The Chicago-based investment bank owned more than 3.8 million NXTM shares as of Dec. 31, 2012, up 19.5% from the 3.2 million shares it owned at the close of 2011.

That amounts to a 6.5% stake in Lawrence, Mass.-based NxStage, which makes home hemodialysis equipment.

Sign up to get our free newsletters delivered straight to your inbox

 Covidien's Mallinckrodt pharma spinout will list on NYSE
Covidien (NYSE:COV) said the spinout of its pharmaceuticals business, Mallinckrodt, will list on the New York Stock Exchange under the MNK symbol. The spinout is expected to take effect some time in the middle of 2013.
Read more

Comments